Scratching Beneath the Surface: Seven Ways to Elevate Conversations With Patients About Their Skin Conditions August 9, 2024
PsO Pipeline Watch: Alumis Initiates Phase 3 Clinical Program Evaluating Its Oral TYK2 Inhibitor in Moderate-to-Severe Plaque PsO July 29, 2024
Arcutis Submits sNDA to FDA for ZORYVE Foam 0.3% for Scalp and Body Psoriasis in Adults and Adolescents Ages 12 and Older July 23, 2024